Tivozanib response prediction

Details for Australian Patent Application No. 2009349657 (hide)

Owner AVEO Pharmaceuticals Inc.

Inventors Lin, Jie; Robinson, Murray; Feng, Bin; Sun, Wenping Kathryn

Agent Cullens

Pub. Number AU-A-2009349657

PCT Pub. Number WO2011/005273

Priority 12/498,183 06.07.09 US

Filing date 19 October 2009

Wipo publication date 13 January 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/005273 Priority application(s): WO2011/005273

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009349683-Method and apparatus of forming integrated multilayer fabrics

2009349654-Peracid/peroxide composition, process for accurately making the same, and method for use as an evaporating film anti-microbial solution and as a photosensitizer